Consultations

Public consultation on proposed human medicines fees 2019

Start Date of Consultation: 3rd October 2018

Closing Date of Consultation: 31st October 2018

HPRA wishes to seek comments on the annual review and proposal for fees 2019.

Please send any comments or questions on these proposals by email to feesconsultation@hpra.ie.

Public consultation on proposed human medicines fees 2019

A response document will be published providing a general overview of the comments received and the changes made to the proposals as a result.

The consultation complies with government policy on public consultation, as described in the document ‘Reaching out: Guidelines on Consultation for Public Sector Bodies’.

HPRA

3rd October 2018

Outcome to public consultation on proposed Human and Veterinary Medicines and Compliance Fees for 2018

The public consultation on the annual review and proposal for fees 2018 was closed on 31st October 2017

The HPRA would like to thank everybody who contributed to the process. 

Please find below a response document providing a general overview of the comments received and the changes made to the proposals as a result.

Outcome of the Process - Public Consultation on proposed Human and Veterinary Medicines and Compliance Fees for 2018

Guide to Biosimilars for Healthcare Professionals and Patients

The public consultation on the Guide to Biosimilars for Healthcare Professionals and Patients was closed on 22nd May 2015. Inputs to this consultation continued to be received and were accepted after this date. The HPRA would like to thank everybody who contributed to the process. Below is a document summarising the outcome of the consultation process.

The guide is intended to provide information on the regulation, prescribing, dispensability and traceability of biosimilar medicines in Ireland. The guide is targeted primarily at healthcare professionals but is also relevant to patients, manufacturers, distributors and those involved in hospital procurement.

The guide was open for public consultation to gather feedback from stakeholders as to whether it provided enough relevant information about biosimilars to meet their needs. The content of the guide has been amended to take account of the comments received as appropriate.

Response Document - Public Consultation on Guide to Biosimilars for Healthcare Professionals and Patients
 

Guide to Biosimilars for Healthcare Professionals and Patients



Human medicines fees consultation 2016.

The public consultation on the annual review and proposal for fees 2016 was closed on 30th October 2015.
The HPRA would like to thank everybody who contributed to the process.
Please find below a response document providing a general overview of the comments received and the changes made to the proposals as a result.

Outcome of the Process - Public Consultation on Proposed Fees for 2016

HPRA Consultations

Please send any comments or questions to feesconsultations@hpra.ie 

This consultation complies with government policy on public consultation, as described in the document ‘Reaching out: Guidelines on Consultation for Public Sector Bodies’.